Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-017-2536-x
Abstract: AbstractPurposeDocetaxel (DTX) is a standard chemotherapeutic drug for castration-resistant prostate cancer (CRPC), although adverse events are common. To overcome this problem, researchers have evaluated the efficacy of DTX treatment in combination with other drugs. Naftopidil… read more here.
Keywords: combination; treatment; induced apoptosis; dtx ... See more keywords